We use cookies to tailor your experience and present relevant ads. By clicking “Accept”, you agree that cookies can be placed per our Privacy Policy

Advertisement

TOPIC

/ company

Wuxi Biologics

Wuxi Biologics

Wuxi Biologics is a pharmaceutical research and services company based in Wuxi, Jiangsu province. It counts 16 of the world's top 20 drug makers as customers and 28 of China's 50 largest medicine producers. The company supplied ingredients for AstraZeneca's Covid-19 vaccine. It is one of six businesses founded by its chairman Ge Li, along with Wuxi Apptec.

Chairman / President

Li Ge

CEO / Managing Director

Chen Zhisheng

CFO / Finance Director

Tu Ming

Industry

Biopharmaceutical

Website

wuxibiologics.com.cn

Headquarters address

No. 108 Mashan Meiliang Road, Binhu Distroct, Wuxi City, Jiangsu Province, China

Stock Code

SEHK:2269

Year founded

2010

LATEST China Science NEWS

Chinese scientists double artillery gun lifespan with ancient chromium tech

1 Aug 2025 - 10:00PM

Bronze swords buried with the Terracotta Army of China’s first emperor have provided the inspiration for a way to tackle one of modern artillery’s most persistent challenges – barrel erosion. Photo: EPA-EFE

Brain drain of US climate scientists may signal shift in scientific gravity

6 hours agovideocam

The US appears to be losing its climate scientists under the Trump administration, experts say. Illustration: Shutterstock

PLA unveils 10GW microwave weapon design with ‘superradiance’ tech

31 Jul 2025 - 10:55PM

An HPM3000 high-powered microwave weapon system on display at the Zhuhai air show. Chinese researchers have unveiled a design that outlines a compact, relativistic electron beam device that could generate a rapid-fire sequence of sub-nanosecond-scale microwave bursts. Photo: SCMP

‘Extreme limits’: China-led mission discovers Earth’s deepest animal oasis

1 Aug 2025 - 7:50PMvideocam

Tubeworms called frenulate siboglinids with small molluscs on the tops of the tubes are seen at a depth of 9,320 metres (30,500 feet) in Wintersweet Valley. Photo: Handout via Reuters

China’s Shenzhou-19 astronauts reveal record spacewalk featured surprise repair

31 Jul 2025 - 4:05PMvideocam

Spacewalks are considered some of the most dangerous activities in space exploration, and extravehicular tasks are typically planned and rehearsed. Photo: Xinhua

MORE China Science NEWS

A crane lifts cargo from a container ship at the Port of Oakland in Oakland, California on July 14, 2025. Photo: EPA

Hong Kong stock market

Hong Kong stocks sustain 3-year-high level on trade optimism

A US deal with Japan and scheduled talks with China reduce concerns about damage to the global economy from trade conflicts.

23 Jul 2025 - 4:37PM

Hong Kong stock market

Hong Kong stocks cap weekly gain on earnings optimism

11 Jul 2025 - 4:39PM

Hong Kong stock market

Hong Kong stocks gyrate amid Iran conflict after US strike, Hormuz threat

24 Jun 2025 - 11:11AM

Hong Kong stock market

Hong Kong stocks rise on China policy hopes after soft economic data

China’s industrial output and fixed-asset investment fell short in May, and the downturn in the property market deepened.

16 Jun 2025 - 4:40PM

Workers pack knives at a factory in Yangjiang, south China’s Guangdong province, on June 11, 2025. Photo: Xinhua

Hong Kong stock market

Hong Kong stocks erase gains amid ongoing US-China trade talks

Investors appear to look more cautiously at ongoing US-China trade talks in London.

10 Jun 2025 - 4:55PM

Hong Kong stock market

Hong Kong stocks jump as US blocks Trump’s tariffs in win for global trade

Hang Seng Index approached a two-month high on bets global trade relations and market sentiment will improve.

29 May 2025 - 4:51PMvideocam

Advertisement

Advertisement

Advertisement

Hong Kong stock market

Hong Kong stocks gain on earnings boost as Meituan beats market consensus

Gains limited by losses in leading carmakers amid lingering concerns about a prolonged price war.

27 May 2025 - 5:06PMvideocam

Exchange Square in Central. Hong Kong. Photo: Sam Tsang

Biomedicine: Companies

Big Chinese pharma can beat Trump’s policies with cost efficiencies: analysts

Trump seeks to slash domestic drug prices, bring back pharmaceutical manufacturing to the US and slap tariffs on imports.

13 May 2025 - 7:38AMvideocam

China Future Tech briefing

Biomedicine | China’s biomedical sector braces for headwinds

The coast isn’t entirely clear for the world’s second-largest biomedical sector, which faces possible tariff increases and US import curbs.

25 Mar 2025 - 4:24PM

Biomedicine: Companies

China’s WuXi Biologics to sell Irish vaccine facility to Merck as US curbs loom

US passed Biosecure Act which would ban federal contracts with targeted firms and their business partners. Legislation explicitly names WuXi.

7 Jan 2025 - 3:36AM

Biomedicine: Companies

WuXi AppTec, WuXi Biologics surge on slimmer chances of Biosecure Act’s passage

The bill’s absence from the proposed amendments to the US National Defence Authorisation Act comes as a reprieve for the two biotech firms.

9 Dec 2024 - 2:40PM

WuXi AppTec says it provides US lawmakers and federal agencies with information about the services it provides to customers in the US and around the world. Photo: Shutterstock

Biomedicine: Policy

Shanghai to back local biopharma firms’ overseas push, regulatory compliance

The initiative aims to generate about US$7 billion from medical product exports by 2027.

1 Nov 2024 - 7:00AMvideocam

WuXi AppTec, WuXi Biologics rise in Hong Kong as some operations go up for sale

The gains were made on the back of a report that said the two firms plan to sell certain overseas operations amid heightened US scrutiny.

13 Jan 2025 - 2:37PM

US-China relations

Senior US official lauds China cooperation on tech-transfer controls

‘End-use checks’ have improved since the pandemic, but pending congressional legislation is keeping mainland firms in limbo.

13 Sep 2024 - 4:47AMvideocam

Matthew Axelrod (right), US assistant secretary for export enforcement at the Department of Commerce, speaks at the Centre for Strategic and International Studies in Washington on Thursday, with William Reinsch of CSIS.

US-China relations

‘China week’ at US House puts biotech firms, Hong Kong offices in cross hairs

Most of the scheduled 28 items have bipartisan support and follow efforts to tackle national and economic security threats posed by Beijing.

10 Sep 2024 - 12:46AMvideocam

Various pieces of US legislation intended to blunt China’s influence and competitive edge are soon due for consideration in Washington. Photo: Shutterstock

Hong Kong stock market

Hong Kong stocks surrender rally as WuXi Bio slumps 21% while Tencent, Li Auto gain

Stocks declined, capping another week of losses, after WuXi Biologics suffered another major plunge. Market surrendered an earlier rally fuelled by favourable Beijing policy and robust EV deliveries in January.

2 Feb 2024 - 4:47PM

Hong Kong stock market

Hong Kong stocks rebound as WuXi Bio, Sands get support to stem market rout

Stocks rebound from a 13-month low, snapping a three-day slump. Some companies are quickly pushing for buy-backs to help stem losses and shore up market confidence.

6 Dec 2023 - 4:53PM

Advertisement

Advertisement

Advertisement

Hong Kong IPO: WuXi Biologics unit eyes up to US$520 million in biotech push

WuXi XDC, a 60 per cent-owned unit of WuXi Biologics, could raise as much as US$520 million, including excess share allotment, based on the top end of its IPO price range.

7 Nov 2023 - 2:30PMvideocam

People work at the WuXi Biologics’ factory in Leverkusen, Germany, in this 2023 handout picture. Photo: Reuters

China’s Wuxi Biologics to spin off international unit in Hong Kong IPO

Capital raised from the IPO of Wuxi XDC will go towards building new manufacturing facilities in Singapore, expanding production capacity in China, strategic investments and acquisitions, according to an exchange filing.

10 Jul 2023 - 12:55PMvideocam

Hong Kong stock market

Most Hong Kong stocks rise as Beijing raises stimulus policy hopes

Most stocks on the Hang Seng Index rose on the prospect that Beijing will double down on policy measures to boost economic growth.

13 Sep 2022 - 4:44PM

Hong Kong stock market

WuXi Biologics suspends trading after US list sparks record 32 per cent slump

WuXi Biologics sank by as much as 32 per cent, its steepest on record, before trading was suspended for an announcement. Some US$14.7 billion of market value in two related companies was erased in the sell-off.

8 Feb 2022 - 5:10PMvideocam

The pharmaceutical research and services company is based in WuXi city, Jiangsu province. Photo: Handout

Hong Kong stock market

Hang Seng slips as WuXi Biologics sink by record after US red-flag list

Stocks slipped for a second day after the US added 33 Chinese companies including WuXi Biologics under its ‘unverified’ list with export restrictions. Alibaba fell again amid speculation insiders are preparing to sell.

8 Feb 2022 - 5:14PMvideocam

Bears are winning the day as stocks slide for a second day in Hong Kong on US red-flag list. Photo: Reuters

Hong Kong stocks decline as Wuxi Biologics, Alibaba pace tech losses

Hong Kong stocks declined amid concerns a surge this week to a three-month high may be too excessive amid debates about the strength of global economic recovery and the outlook for Fed tapering.

2 Jun 2021 - 4:47PMvideocam

Investors swoop in on WuXi Biologics shares as owner trims stake

The sell-down programme by controlling shareholder Biologics Holdings has raised HK$54.9 billion (US$7.1 billion) in funds over 10 disposals since 2017.

8 Jan 2021 - 8:39AM

Hang Seng Index

China’s telecom giants surge on NYSE reversal, WuXi slides as insider sells

Hong Kong and China stocks gained as Chinese telecom giants surged after the New York Stock Exchange scraps its delisting plan. WuXi Biologics slumped as an insider trimmed his stake for a second time in four months.

5 Jan 2021 - 5:19PM

Chinese telecom giants surged after the NYSE scrapped its decision to delist their ADRs four days after announcing the move. Photo: AP

Hong Kong stock market

Hong Kong stocks rise on vaccine, stimulus news while job cuts buoy Cathay

Hang Seng Index completed a fourth day of gains, with drug maker WuXi Biologics rallying by the most in two years. Alibaba Group powered past the HK$300 mark, adding almost 9 per cent alone this month.

25 Oct 2020 - 5:09PM

People walk by an electronic stock board of a securities firm in Tokyo, Japan in March 2020. Stocks in Asia-Pacific markets get a boost from progress in US stimulus talks. Photo: AP

WuXi Biologics’ largest investor sells stake for US$893 million windfall

WuXi’s stock has doubled in price since the start of this year, and WuXi Biologics Holdings raised HK$6.1 billion (US$893 million) by selling a 2.43 per cent stake after the market closed on Tuesday. It has now reaped HK$40.7 billion from selling WuXi shares.

2 Sep 2020 - 10:29PMvideocam

Hang Seng Index

Xiaomi outpaces Alibaba, Wuxi since being tapped for Hang Seng Index

Xiaomi, Alibaba and Wuxi Biologics join the Hang Seng Index on September 7. Passive fund managers will add them to their holdings. This coming week, Xiaomi reports results on Wednesday. Expect more fireworks, analysts say, after this past week’s rollicking trading.

23 Aug 2020 - 4:57PMvideocam

Advertisement

Advertisement

Advertisement

Help preserve 120 years of quality journalism.

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement